Devices for treating obstructive sleep apnea
Search documents
Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-11 23:15
分组1 - Inspire Medical Systems reported quarterly earnings of $1.65 per share, exceeding the Zacks Consensus Estimate of $0.69 per share, and up from $1.15 per share a year ago, adjusted for non-recurring items [1] - The earnings surprise for this quarter was +137.65%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - The company posted revenues of $269.08 million for the quarter, surpassing the Zacks Consensus Estimate by 0.03%, and up from $239.72 million year-over-year, also exceeding revenue estimates in the last four quarters [3] 分组2 - The stock has underperformed the market, losing about 26.1% since the beginning of the year, while the S&P 500 gained 1.4% [4] - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $212.59 million, and for the current fiscal year, it is $1.72 on $1 billion in revenues [8] - The Medical Info Systems industry is currently ranked in the bottom 34% of over 250 Zacks industries, indicating potential challenges for stock performance [9]
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-07-28 15:06
Wall Street expects a year-over-year decline in earnings on higher revenues when Inspire Medical Systems (INSP) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on August 4, might help the stock move higher if these key numbers are better than e ...
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy
ZACKS· 2025-05-07 17:00
Investors might want to bet on Inspire Medical Systems (INSP) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Indiv ...